Dublin, Dec. 20, 2016 -- Research and Markets has announced the addition of the "Insomnia Drugs Price Analysis and Strategies - 2016" report to their offering.
The latest research Insomnia Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Insomnia market.
The research answers the following questions:
What are the key drugs marketed for Insomnia and their clinical attributes? How are they positioned in the Global Insomnia market?
What are the unit prices and annual treatment cost for Insomnia therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
What are the unmet needs in the global Insomnia drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Insomnia?
Research Scope:
Insomnia Treatment Options - Identify key drugs marketed and prescribed for Insomnia in the US, Germany, France, Italy, Spain, UK, Japan including trade name, molecule name, and company
Insomnia Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Insomnia
Market Positioning - Identify how drugs are clinically and commercially positioned in the global Insomnia market
Insomnia Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed for Insomnia in the US, Germany, France, Italy, Spain, UK, Japan. Find out how the price advanced from 2012 and forecast to 2021
Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape in the US, Germany, France, Italy, Spain, UK, Japan
Insomnia New Drug Pricing - Identify the effective pricing strategy for a new drug launch in the US, Germany, France, Italy, Spain, UK, Japan
This research will help executives
- Identify clinical attributes of your competitor drugs
- Find out how the marketed products for Insomnia are clinically and commercially positioned
- Understand the price of your competitor drugs by countries
- Use Insomnia drugs price data for market sizing, drug sales forecast, budgeting, competitive intelligence, HEOR, and reimbursement
- Find out the pricing and reimbursement landscape by countries
- Identify the unmet need in global Insomnia market
- Identify the effective pricing for a new drug
Key Topics Covered:
1. Insomnia Treatment Options
2. Insomnia Drugs Clinical Attributes
3. Insomnia Drugs Market Positioning
4. Insomnia Drugs Price Analysis
4.1. Insomnia Drugs Price Analysis - US
4.2. Insomnia Drugs Price Analysis - Germany
4.3. Insomnia Drugs Price Analysis - France
4.4. Insomnia Drugs Price Analysis - Italy
4.5. Insomnia Drugs Price Analysis - Spain
4.6. Insomnia Drugs Price Analysis - UK
4.7. Insomnia Drugs Price Analysis - Japan
5. Insomnia Drugs Price Benchmarks
6. Drug Pricing & Reimbursement Landscape
6.1. Drug Pricing & Reimbursement Landscape - US
6.2. Drug Pricing & Reimbursement Landscape - Germany
6.3. Drug Pricing & Reimbursement Landscape - France
6.4. Drug Pricing & Reimbursement Landscape - Italy
6.5. Drug Pricing & Reimbursement Landscape - Spain
6.6. Drug Pricing & Reimbursement Landscape - UK
6.7. Drug Pricing & Reimbursement Landscape - Japan
7. Insomnia Drugs Price Forecast
8. Insomnia Market Unmet Needs
9. Insomnia New Drug Pricing
10. Research Methodology
Table 1: Insomnia Marketed Drugs, Global, 2016
Table 2: Insomnia Drugs Clinical Attribute Analysis, Global, 2016
Table 3: Insomnia Drugs Unit Price, Global, 2012 - 2016
Table 4: Insomnia Drugs Annual Treatment Cost, Global, 2012 - 2016
Table 5: Insomnia Drugs Unit Price, US, 2012 - 2016
Table 6: Insomnia Drugs Annual Treatment Cost, US, 2012 - 2016
Table 7: Insomnia Drugs Unit Price, Germany, 2012 - 2016
Table 8: Insomnia Drugs Annual Treatment Cost, Germany, 2012 - 2016
Table 9: Insomnia Drugs Unit Price, France, 2012 - 2016
Table 10: Insomnia Drugs Annual Treatment Cost, France, 2012 - 2016
Table 11: Insomnia Drugs Unit Price, Italy, 2012 - 2016
Table 12: Insomnia Drugs Annual Treatment Cost, Italy, 2012 - 2016
Table 13: Insomnia Drugs Unit Price, Spain, 2012 - 2016
Table 14: Insomnia Drugs Annual Treatment Cost, Spain, 2012 - 2016
Table 15: Insomnia Drugs Unit Price, UK, 2012 - 2016
Table 16: Insomnia Drugs Annual Treatment Cost, UK, 2012 - 2016
Table 17: Insomnia Drugs Unit Price, Japan, 2012 - 2016
Table 18: Insomnia Drugs Annual Treatment Cost, Japan, 2012 - 2016
Table 19: Insomnia Drugs Price Comparison Benchmarks, Global, 2016
Table 20. Drug Pricing Landscape by Countries, 2016
Table 21: Drug Reimbursement Landscape by Countries, 2016
Table 22: Insomnia Drugs Price Forecast, Global, 2016 - 2021
Table 23: Insomnia Drugs Price Forecast, US, 2016 - 2021
Table 24: Insomnia Drugs Price Forecast, Germany, 2016 - 2021
Table 25: Insomnia Drugs Price Forecast, France, 2016 - 2021
Table 26: Insomnia Drugs Price Forecast, Italy, 2016 - 2021
Table 27: Insomnia Drugs Price Forecast, Spain, 2016 - 2021
Table 28: Insomnia Drugs Price Forecast, UK, 2016 - 2021
Table 29: Insomnia Drugs Price Forecast, Japan, 2016 - 2021
Table 30: Insomnia Market Unmet Needs
Table 31: Insomnia New Drugs Pricing, Global, 2016 - 2021
Figure 1: Insomnia Drugs Market Positioning, Global, 2016
Figure 2: Insomnia Drugs Unit Price, Global, 2012 - 2016
Figure 3: Insomnia Drugs Annual Treatment Cost, Global, 2012 - 2016
Figure 4: Insomnia Drugs Unit Price, US, 2012 - 2016
Figure 5: Insomnia Drugs Annual Treatment Cost, US, 2012 - 2016
Figure 6: Insomnia Drugs Unit Price, Germany, 2012 - 2016
Figure 7: Insomnia Drugs Annual Treatment Cost, Germany, 2012 - 2016
Figure 8: Insomnia Drugs Unit Price, France, 2012 - 2016
Figure 9: Insomnia Drugs Annual Treatment Cost, France, 2012 - 2016
Figure 10: Insomnia Drugs Unit Price, Italy, 2012 - 2016
Figure 11: Insomnia Drugs Annual Treatment Cost, Italy, 2012 - 2016
Figure 12: Insomnia Drugs Unit Price, Spain, 2012 - 2016
Figure 13: Insomnia Drugs Annual Treatment Cost, Spain, 2012 - 2016
Figure 14: Insomnia Drugs Unit Price, UK, 2012 - 2016
Figure 15: Insomnia Drugs Annual Treatment Cost, UK, 2012 - 2016
Figure 16: Insomnia Drugs Unit Price, Japan, 2012 - 2016
Figure 17: Insomnia Drugs Annual Treatment Cost, Japan, 2012 - 2016
Figure 18: Insomnia Drugs Price Comparison Benchmarks, Global, 2016
Figure 19: Insomnia Drugs Price Forecast, Global, 2016 - 2021
Figure 20: Insomnia Drugs Price Forecast, US, 2016 - 2021
Figure 21: Insomnia Drugs Price Forecast, Germany, 2016 - 2021
Figure 22: Insomnia Drugs Price Forecast, France, 2016 - 2021
Figure 23: Insomnia Drugs Price Forecast, Italy, 2016 - 2021
Figure 24: Insomnia Drugs Price Forecast, Spain, 2016 - 2021
Figure 25: Insomnia Drugs Price Forecast, UK, 2016 - 2021
Figure 26: Insomnia Drugs Price Forecast, Japan, 2016 - 2021
Figure 27: Insomnia New Drugs Pricing, Global, 2016 - 2021
For more information about this report visit http://www.researchandmarkets.com/research/qddmt5/insomnia_drugs
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs , Central Nervous System Drugs


Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



